SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Camlin Fine Sciences Ltd

BSE: 532834 NSE: CAMLINFINE ISIN: INE052I01032
  |   Sector:  Chemicals & Fertilizers   |   Industry:  Chemicals

Snapshot

Q.1 Which industry/sub-sector does Camlin Fine Sciences Ltd belong to?
Camlin Fine Sciences Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.
Q.2 Is Camlin Fine Sciences Ltd a good quality company?
Camlin Fine Sciences Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Camlin Fine Sciences Ltd undervalued or overvalued?
Camlin Fine Sciences Ltd appears Somewhat Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Camlin Fine Sciences Ltd a good buy now?
Camlin Fine Sciences Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd revenue growth is 14.6% for FY-2025 , which is above its 5 year CAGR of 8.9% , indicating faster growth.
Q.2 Gross Profit margin of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd Gross profit margin which is the profit after deduction of direct costs, is 2.8% for FY-2025 , which is below its 5 year median of 5.8% , indicating decreasing margins.
Q.3 Operating Profit Margin of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 8.93% for FY-2025 , which is below its 5 year median of 11.56% indicating decreasing margins.
Q.4 Net Profit Margin of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd Net Profit Margin is -8.61% for FY-2025 , is below with its 5 year median of 1.38%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 2.8 5.8
Operating Profit Margin 8.93 11.56
Net Profit Margin -8.61 1.38
Q.5 Return on Asset of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd Return on Asset is -4.83%, which is below its 5 year historical median of 0.85%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd Return on equity is -9.85% for FY-2025 , which is below its historical median of 2.1%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd Return on capital employed is -3.85% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd Cash conversion cycle is 170 days, above its historical median of 170 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.56 0.56
ROE -9.85 2.1
ROCE -3.85 6.9
Cash Conversion Cycle 170 days 170 days
Q.9 Debt to Equity ratio of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd Debt-to-Equity ratio is 0.52 , which is above with the industry average of 0.13 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Camlin Fine Sciences Ltd?
Camlin Fine Sciences Ltd Debt to cash flow from operations is 20.21 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Camlin Fine Sciences Ltd?
Promoters hold 48.03% of the Camlin Fine Sciences Ltd, with 16.58% of their stake pledged, indicating high pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Camlin Fine Sciences Ltd vs industry peers?
Camlin Fine Sciences Ltd revenue CAGR is 8.86% , compared to the industry median CAGR of 7.7% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 886.5 202
Gross Profit 24.8 23.6
Operating Profit 79 24
Net Profit -76 12
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.56 0.93
ROE -9.85 10.18
ROCE -3.85 13.07
Cash Conversion Cycle (days) 169.99 62

Valuation & price assessment

Q.1 Stock return of Camlin Fine Sciences Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 0.9% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 0.9% -4.7% -12.9% -36.1%
Q.3 Valuation ratios of Camlin Fine Sciences Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings - 35.39 41.15
Price to Book 2.19 3.07 2.38
Price to Sales 2.21 2.09 1.93
EV to EBITDA 23.23 17.34 13.71

Check more companies

1. Navin Fluorine Intl
2. Godrej Industries
3. Deepak Nitrite
4. Atul
5. Tata Chemicals
6. BASF India
7. Aarti Inds
8. Aether Industries
9. Deepak Fert & Petro
10. Fine Organic Inds.
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×